Triana Biomedicines
Lexington
About Triana Biomedicines
Triana Biomedicines is a developer of a molecular glue discovery platform to regulate disease targets that are difficult to address with any other modality. Triana’s drug discovery engine is powered by high-resolution structural insights, state-of-the-art in silico tools, and bespoke chemical libraries. The research team has validated the best-in-class platform and initiated multiple programs across different disease areas.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $280.8M
- Funding stage: Early Stage Venture
- Last round: Series B (Dec 2025)
- Website: trianabio.com
- Phone: (781) 317-4414
Industries & Categories
Biopharma, Biotechnology, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/triana-biomedicines-12075 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.